Aurora Cannabis Inc. Stock Analysis & AI Score
Aurora Cannabis Inc. (ACB) has an ST Score of 50.9 (C+), driven by its Financial Strength (A) and held back by its Profitability (D-). Analysts rate it Hold with a $5.92 price target (+49.1% upside).
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
AI Daily Briefing
Analysis by AIACB Stock Price History
ACB Technical Indicators
FMPEarnings Surprises
Analyst Forecast
Revenue Mix
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Analyst Price Target
ESG Score
ACB Latest Stock News
ST Score
Aurora Cannabis Inc. (ACB) has an ST Score of 50.9 (C+), driven by its Financial Strength (A) and held back by its Profitability (D-). Analysts rate it Hold with a $5.92 price target (+49.1% upside).
- Strongest
- Financial StrengthA
- Weakest
- ProfitabilityD-
All factor grades
- Financial StrengthA
- MomentumB+
- ValuationB
- ForecastB
- GrowthC+
- SentimentC+
- ProfitabilityD-
- Piotroski2/9
Press Releases
Company Contact Details
ACB stock: frequently asked questions
What is ACB's ST Score?
Aurora Cannabis Inc. (ACB) has an ST Score of 50.9 (C+), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is ACB a buy, hold, or sell?
Analysts rate ACB a Hold, with a price target of $5.92 (+49.1% vs the current price). Our ST Score grades it C+ (50.9/100). The ST Score is a data-driven signal, not a recommendation.
What are ACB's factor grades?
Valuation B, Profitability D-, Financial Strength A, Momentum B+, Growth C+, Forecast B, Sentiment C+.
What is ACB's valuation grade?
Aurora Cannabis Inc. (ACB) earns a valuation grade of B, measured against Drug Manufacturers - Specialty & Generic peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is ACB's growth grade?
Aurora Cannabis Inc. (ACB) earns a growth grade of C+, measured against Drug Manufacturers - Specialty & Generic peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is ACB's profitability grade?
Aurora Cannabis Inc. (ACB) earns a profitability grade of D-, measured against Drug Manufacturers - Specialty & Generic peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is ACB's financial strength grade?
Aurora Cannabis Inc. (ACB) earns a financial strength grade of A, measured against Drug Manufacturers - Specialty & Generic peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for ACB?
The average analyst price target for Aurora Cannabis Inc. (ACB) is $5.92 from 14 analysts, which is +49.1% versus the recent price of $3.97.
What is ACB's Piotroski score?
Aurora Cannabis Inc. (ACB) has a Piotroski F-Score of 2 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.